Your session is about to expire
← Back to Search
Decidual Stromal Cells (DSC) for COVID-19
Study Summary
This trial will test how safe and effective decidual stromal cells are in treating patients with respiratory failure caused by COVID-19.
- COVID-19
- Coronavirus
- Acute Respiratory Distress Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research the inaugural venture into its experimental field?
"Decidual Stromal Cells (DSC) have been researched since 2018, when the initial trial was sponsored by Pluristem Ltd. After completing the first study of 240 patients in that year, this medication achieved Phase 3 approval and is now present in 6 different cities across 6 nations with three active trials ongoing."
Does this study permit individuals younger than 60 years to participate?
"Eligible participants must be above the age of legal majority and under 75 years old."
Are there any preceding experiments that have utilized Decidual Stromal Cells (DSC)?
"Presently, three trials exploring Decidual Stromal Cells (DSC) are taking place. One is currently in its final phase of clinical research. While the majority of studies for this treatment take place Kfar-Saba, 21 other locations across the US have initiated their own investigations into DSC efficacy."
Who is eligible for enrollment into this medical research?
"This research is looking to enlist 19 individuals, aged 18-75 years old, who have been afflicted with the SARS-CoV-2 virus. Other prerequisites include ARDS not caused by a heart concern, ability to provide consent or an LAR can do so on their behalf and receiving mechanical ventilation."
How many individuals have been accepted to participate in this research?
"Unfortunately, no new patients are being accepted for this trial at the present time. Initially posted on September 25th 2020 and most recently updated on May 9th 2022, other potential studies may be of interest such as 1334 trials with active recruitment related to Covid-19 or 3 studies focused on Decidual Stromal Cells (DSC)."
Are new participants being accepted for this research effort?
"At present, this research is not accepting subjects. It was first announced on September 25th 2020 and its information was most recently revised on May 9th 2022. For those looking for other trials, there are currently 1334 studies actively seeking participants with COVID-19 as well as 3 DSC clinical experiments that are open to recruitment."
Share this study with friends
Copy Link
Messenger